Chromosome | Affected cytobands | Region start-end positions (Mb) | Total length of aberrant regions (Mb) | No. of samples (%) |
---|---|---|---|---|
Regions of CN gain | Â | Â | Â | Â |
4 | p15.1-q13.1 | 29–62 | 5 | 11 (41%) |
 | q26-q28.3 | 117–137 | 5 | 11 (41%) |
5 | p15.1-p14.1 | 17–29 | 10 | 11 (41%) |
 | q11.2-q12.3 | 53–66 | 5 | 11 (41%) |
 | q14.3-q21.3 | 84–105 | 12 | 11 (41%) |
 | q23.1-q34 | 119–163 | 11 | 11 (41%) |
7 | p21.3-p21.2 | 8–14 | 5 | 11 (41%) |
 | q21.11 | 81–85 | 4 | 11 (41%) |
 | q31.31-q31.32 | 118–122 | 4 | 11 (41%) |
11 | p15.1-q12.1 | 21–57 | 11 | 11 (41%) |
 | q14.2-q22.3 | 87–107 | 10 | 11 (41%) |
12 | q12-q15 | 35–69 | 10 | 11 (41%) |
 | q21.31-q23.1 | 82–100 | 5 | 11 (41%) |
14 | q21.1-q21.3 | 41–48 | 4 | 11 (41%) |
16 | p11.2-q11.1 | 34–39 | 5 | 11 (41%) |
19 | p12-p11 | 24–28 | 4 | 12 (44%) |
22 | p13-p11.2 | 0–9 | 9 | 12 (44%) |
Regions of CN loss | Â | Â | Â | Â |
1 | p36.32-p36.31 | 5–7 | 2 | 25 (93%) |
 | p36.11 | 24–26 | 2 | 21 (78%) |
3 | p26.3-p26.2 | 3–5 | 2 | 26 (96%) |
 | p25.3-p25.1 | 9–14 | 5 | 26 (96%) |
9 | q33.3-q34.11 | 128–130 | 2 | 21 (78%) |
22 | q13.1-q13.2 | 38–40 | 2 | 21 (78%) |